TapewireFind a company

person · Reporting owner

McKelvy Michael E

Disclosed activity across 1 company

Tapewire entity
51664
SEC CIK
0001426872

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Amrize LtdAMRZ · Entity 1392DirectorApril 21, 2026April 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Amrize Ltd

Report date April 21, 2026 · Filed April 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect5,194 Ending reported balance After 2026-04-21 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-04-21 · Tax withholding · Disposed 740 · Balance 2,218

F1: Closing price per share on the trading date of the vesting of restricted stock units.

Row 2 · 2026-04-21 · Grant · Acquired 2,976 · Balance 5,194

F2: Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Closing price per share on the trading date of the vesting of restricted stock units.

F2: Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 21, 2026 Filed Apr 22, 2026 15:00 UTC Amrize Ltd AMRZ · Entity 1392 GrantOrdinary Shares 2,976 $0.00 $0.00
Disclosure

SEC source: 0001426872-26-000001 · primary_doc.xml · nonDerivative · entry 2

McKelvy Michael E · CIK 0001426872 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,194

F2 · shares: Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

Read SEC document
April 21, 2026 Filed Apr 22, 2026 15:00 UTC Amrize Ltd AMRZ · Entity 1392 Tax withholdingOrdinary Shares 740 $57.12 $42,268.80
Disclosure

SEC source: 0001426872-26-000001 · primary_doc.xml · nonDerivative · entry 1

McKelvy Michael E · CIK 0001426872 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,218

F1 · price: Closing price per share on the trading date of the vesting of restricted stock units.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 18:19 UTC Amrize Ltd AMRZ · Entity 1392 GrantOrdinary Shares 2,958 $0.00 $0.00
Disclosure

SEC source: 0002035989-25-000017 · primary_doc.xml · nonDerivative · entry 1

McKelvy Michael E · CIK 0001426872 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,958

F1 · shares: Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.